Stepan Co

Stepan Co

SCL
Stepan CoUS flagNew York Stock Exchange
65.17
USD
-0.11
- -
1.48BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
83.14
84.68
78.14
77.49
83.89
86.61
80.63
81.47
102.35
121.74
102.11
95.49
101.96
106.31
Basic EPS, GAAP
3.22
2.51
3.34
3.78
4.39
4.83
4.47
5.52
6.01
6.46
1.77
2.21
2.05
-0.12
Free Cash Flow per Basic Share
2.54
-0.84
2.83
4.79
5.24
3.67
4.9
4.77
3.15
7.06
7.68
7.1
6.47
6.78
Dividend per Share
0.64
0.68
0.72
0.76
0.82
0.91
1
1.11
1.23
1.34
1.44
1.49
1.53
1.55
Book Value per Share
24.73
24.06
25
28.3
32.88
35.88
39.61
43.91
47.91
52.44
54.36
52
54.99
53.32
Tangible Book Value per Share
23.15
22.61
23.69
26.17
30.94
34.22
37.77
41.59
40.87
45.52
47.66
46.04
49.15
47.69
Basic Weighted Avg Shares
23
23
23
23
23
23
23
23
23
23
23
23
23
23
Sales/Revenue/Turnover
1,881
1,927
1,776
1,766
1,925
1,994
1,859
1,870
2,346
2,773
2,326
2,180
2,332
2,433
Operating Margin (%)
5.86
4.91
6.75
7.64
8.2
7.62
6.96
9.22
7.45
7.51
3.14
3.25
2.98
3.34
Depreciation Expense
56
64
67
75
79
81
79
82
91
95
105
112
126
129
Net Income, GAAP
73
57
76
86
101
111
103
127
138
147
40
50
47
-3
Effective Tax Rate (%)
24.36
24.43
26.07
24.27
31.41
19.35
18.11
25.38
20.08
22.02
16.92
16.66
21.72
63.98
Profit Margin (%)
3.87
2.96
4.28
4.88
5.23
5.57
5.55
6.78
5.87
5.31
1.73
2.31
2.01
-0.11
Working Capital
340
326
376
388
468
495
480
489
413
374
244
141
192
128
LT Debt
235
247
313
289
268
239
228
212
380
506
459
390
390
289
Total Equity
554
537
558
636
741
808
892
988
1,074
1,166
1,216
1,170
1,244
1,212
Return on Invested Capital (%)
11.29
8.84
10.54
11.2
11.02
11.68
9.59
10.89
10.29
9.92
3.27
3.14
2.9
- -
Return on Capital (%)
10.92
8.07
10.21
10.54
11.09
11.46
10.11
11.04
10.49
9.44
2.86
3.52
3.57
2.17
Return on Common Equity (%)
14.15
10.5
13.91
14.47
14.66
14.36
12.14
13.5
13.37
13.14
3.37
4.22
3.89
-0.22

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
286
323
403
LT Borrowings
341
328
244
LT Finance Leases
49
47
45
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
23
23
23
Market Capitalization
1,071
1,135
1,267

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
859
906
975
Cash, Cash Equivalents & STI
133
141
114
Accounts Receivable, Net
388
434
492
Inventories
299
289
324
Total Current Liabilities
666
720
847
Payables & Accruals
381
397
444
ST Debt
286
323
403
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.47%
4.81%
6.33%
Free Cash Flow
16.2%
16.3%
-8.74%
Net Income, GAAP
1.76%
-7.76%
-6.9%
Sales/Revenue/Turnover
3.41%
5.65%
6.96%
Total Cash Common Dividend
7.99%
6.68%
3.18%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
551
556
547
526
2,180
2025
593
595
590
554
2,332
2026
605
684
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.61
0.42
1.03
0.15
2.21
2025
0.86
0.5
0.47
0.22
2.05
2026
-1.81
1
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.37
0.37
0.37
0.38
1.49
2025
0.38
0.38
0.38
0.39
1.53
2026
0.39
0.39
- -
- -
- -

Company Description

APIChatGPT
CEO
Luis E. Rojo
Full Time Employees
2,328
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
1101 Skokie Boulevard Northbrook IL United States of America 60062
IPO Date
Feb 21, 1973
Website
stepan.com
Business
Stepan Company Stepan Company manufactures specialty and intermediate chemicals for consumer and industrial applications worldwide. Founded in 1932 and headquartered in Northbrook, Illinois, the company operates through three main segments: surfactants, polymers, and specialty products; it serves industries including household and personal care, agriculture, oilfield, construction, food and nutrition, and pharmaceuticals with manufacturing facilities across North America, Europe, Asia, and South America. Its surfactant portfolio, for which it claims status as the world's largest merchant producer of anionic surfactants, encompasses sulfonates, sulfates, phosphate esters, amphoterics, quaternaries, and nonionics used in detergents, shampoos, cleaners, crop protection formulations, fabric softeners, emulsifiers, dispersants, and tank mix adjuvants under brands such as STEPAN®, TOXIMUL®, STEPFAC™, STEPSPERSE®, STEPWET®, STEPOSOL®, STEP-FLOW®, and HALLCOMID®; the polymers segment offers polyester polyols for rigid foam insulation in construction, refrigeration, and CASE (coatings, adhesives, sealants, elastomers) applications; while specialty products include ingredients for antimicrobials, flavors, nutritional supplements, emulsion polymerization, phthalic anhydride, and pharmaceutical excipients, notably processing coca leaf extracts for beverages like Coca-Cola and supplying cocaine derivatives for medicinal use. Stepan Company maintains a broad global footprint with approximately 2,000 employees and sites supporting diverse markets from personal care foaming agents to agricultural dispersants and wetting agents, including advanced formulation services for organic farming and green solvents like methyl esters derived from soybean oil. In recent developments, the company completed the sale of its Philippine subsidiary Stepan Philippines Quaternaries Inc. (SPQI) manufacturing facility to Musim Mas's Masurf Inc. on November 14, 2025, establishing a tolling arrangement to ensure continued Southeast Asian customer service while streamlining focus on core growth assets. Earlier, Stepan boosted its alpha olefin sulfonate (AOS) production capacity by 25% through capital investments and process enhancements, and it expanded alkoxylation capabilities with a $245 million investment in Pasadena, Texas, set for early operations.

Company News

APIChatGPT
  • Stepan Company $SCL Shares Bought by First Trust Advisors LP

  • Stepan Q2 Earnings Call Highlights

  • Stepan (NYSE:SCL) Shares Gap Up on Strong Earnings

  • Stepan Company (SCL) Q2 2026 Earnings Call Transcript

  • Stepan Co. (SCL) Surpasses Q2 Earnings and Revenue Estimates

  • Stepan Declares Quarterly Dividend

  • Stepan Reports Second Quarter 2026 Results

  • My Top 5 Dividend Picks For July

  • Stepan Company's Discount Isn't Over Yet

  • Stepan to Announce Second Quarter 2026 Results on July 29, 2026

  • Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

  • Stepan Co (SCL) Stock Up 3.1% and Still Undervalued -- GF Score: 77/100

  • Stepan Company (SCL) Q1 2026 Earnings Call Transcript

  • Stepan Co. (SCL) Beats Q1 Earnings Estimates

  • Stepan Declares Quarterly Dividend

  • Stepan Reports First Quarter 2026 Results

  • Earnings Preview: Stepan Co. (SCL) Q1 Earnings Expected to Decline

  • Stepan to Announce First Quarter 2026 Results on April 28, 2026

  • SG Americas Securities LLC Boosts Stake in Stepan Company $SCL

  • Stepan Company: The Ride Higher Isn't Over Yet